Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer

Saved in:
Bibliographic Details
Published in:Annals of oncology 1991-04, Vol.2 (4), p.305-306
Main Authors: Rodenburg, C J, Nooter, K, Herweijer, H, Seynaeve, C, Oosterom, R, Stoter, G, Verweij, J
Format: Article
Language:English
Subjects:
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cyclosporins - administration & dosage
Drug Evaluation
Drug Resistance
Female
Humans
Kidney Neoplasms - drug therapy
Male
Middle Aged
Vinblastine - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2221-42a1bf45ee91b978dd03755d8615881705edf80a010c0907cb22d1c5e626ce13
cites cdi_FETCH-LOGICAL-c2221-42a1bf45ee91b978dd03755d8615881705edf80a010c0907cb22d1c5e626ce13
container_end_page 306
container_issue 4
container_start_page 305
container_title Annals of oncology
container_volume 2
creator Rodenburg, C J
Nooter, K
Herweijer, H
Seynaeve, C
Oosterom, R
Stoter, G
Verweij, J
description
doi_str_mv 10.1093/oxfordjournals.annonc.a057941
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80730878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80730878</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2221-42a1bf45ee91b978dd03755d8615881705edf80a010c0907cb22d1c5e626ce13</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhnNQaq3-BCEXvW2dZL-Sg4dS_CgU9NB7yCbZmrKbtMlusf_eLVsQLzPM8L4zLw9CjwTmBHj67H9qH_TO98HJJs6lc96puYS85Bm5QlPgNE3KPM1u0G2MOwAoOOUTNCGsYECLKTp8fcto8GqFY9frE_Y1Vr6trLNui4_WVY2MnXUGS6exOqnGx70P1iUL3HmsbFB9ezSuw23fdFaHfouDiTZ20imDrRumIRpWphnKeRfu0HU9hDX3lz5Dm7fXzfIjWX--r5aLdaIopSTJqCRVneXGcFLxkmkNaZnnmhUkZ4yUkBtdM5BAQAGHUlWUaqJyU9BCGZLO0NN4dh_8oTexE62N5xjSGd9HwaBMgZVsEL6MQhV8jMHUYh9sK8NJEBBnyuI_ZTFSFhfKg__h8qivWqP_3CPi9BfHwISS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80730878</pqid></control><display><type>article</type><title>Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer</title><source>Oxford University Press Archive</source><creator>Rodenburg, C J ; Nooter, K ; Herweijer, H ; Seynaeve, C ; Oosterom, R ; Stoter, G ; Verweij, J</creator><creatorcontrib>Rodenburg, C J ; Nooter, K ; Herweijer, H ; Seynaeve, C ; Oosterom, R ; Stoter, G ; Verweij, J</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/oxfordjournals.annonc.a057941</identifier><identifier>PMID: 1868026</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Cyclosporins - administration &amp; dosage ; Drug Evaluation ; Drug Resistance ; Female ; Humans ; Kidney Neoplasms - drug therapy ; Male ; Middle Aged ; Vinblastine - administration &amp; dosage</subject><ispartof>Annals of oncology, 1991-04, Vol.2 (4), p.305-306</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2221-42a1bf45ee91b978dd03755d8615881705edf80a010c0907cb22d1c5e626ce13</citedby><cites>FETCH-LOGICAL-c2221-42a1bf45ee91b978dd03755d8615881705edf80a010c0907cb22d1c5e626ce13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1868026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodenburg, C J</creatorcontrib><creatorcontrib>Nooter, K</creatorcontrib><creatorcontrib>Herweijer, H</creatorcontrib><creatorcontrib>Seynaeve, C</creatorcontrib><creatorcontrib>Oosterom, R</creatorcontrib><creatorcontrib>Stoter, G</creatorcontrib><creatorcontrib>Verweij, J</creatorcontrib><title>Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Cyclosporins - administration &amp; dosage</subject><subject>Drug Evaluation</subject><subject>Drug Resistance</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney Neoplasms - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Vinblastine - administration &amp; dosage</subject><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEQhnNQaq3-BCEXvW2dZL-Sg4dS_CgU9NB7yCbZmrKbtMlusf_eLVsQLzPM8L4zLw9CjwTmBHj67H9qH_TO98HJJs6lc96puYS85Bm5QlPgNE3KPM1u0G2MOwAoOOUTNCGsYECLKTp8fcto8GqFY9frE_Y1Vr6trLNui4_WVY2MnXUGS6exOqnGx70P1iUL3HmsbFB9ezSuw23fdFaHfouDiTZ20imDrRumIRpWphnKeRfu0HU9hDX3lz5Dm7fXzfIjWX--r5aLdaIopSTJqCRVneXGcFLxkmkNaZnnmhUkZ4yUkBtdM5BAQAGHUlWUaqJyU9BCGZLO0NN4dh_8oTexE62N5xjSGd9HwaBMgZVsEL6MQhV8jMHUYh9sK8NJEBBnyuI_ZTFSFhfKg__h8qivWqP_3CPi9BfHwISS</recordid><startdate>199104</startdate><enddate>199104</enddate><creator>Rodenburg, C J</creator><creator>Nooter, K</creator><creator>Herweijer, H</creator><creator>Seynaeve, C</creator><creator>Oosterom, R</creator><creator>Stoter, G</creator><creator>Verweij, J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199104</creationdate><title>Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer</title><author>Rodenburg, C J ; Nooter, K ; Herweijer, H ; Seynaeve, C ; Oosterom, R ; Stoter, G ; Verweij, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2221-42a1bf45ee91b978dd03755d8615881705edf80a010c0907cb22d1c5e626ce13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Cyclosporins - administration &amp; dosage</topic><topic>Drug Evaluation</topic><topic>Drug Resistance</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney Neoplasms - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Vinblastine - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodenburg, C J</creatorcontrib><creatorcontrib>Nooter, K</creatorcontrib><creatorcontrib>Herweijer, H</creatorcontrib><creatorcontrib>Seynaeve, C</creatorcontrib><creatorcontrib>Oosterom, R</creatorcontrib><creatorcontrib>Stoter, G</creatorcontrib><creatorcontrib>Verweij, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodenburg, C J</au><au>Nooter, K</au><au>Herweijer, H</au><au>Seynaeve, C</au><au>Oosterom, R</au><au>Stoter, G</au><au>Verweij, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>1991-04</date><risdate>1991</risdate><volume>2</volume><issue>4</issue><spage>305</spage><epage>306</epage><pages>305-306</pages><issn>0923-7534</issn><cop>England</cop><pmid>1868026</pmid><doi>10.1093/oxfordjournals.annonc.a057941</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 1991-04, Vol.2 (4), p.305-306
issn 0923-7534
language eng
recordid cdi_proquest_miscellaneous_80730878
source Oxford University Press Archive
subjects Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cyclosporins - administration & dosage
Drug Evaluation
Drug Resistance
Female
Humans
Kidney Neoplasms - drug therapy
Male
Middle Aged
Vinblastine - administration & dosage
title Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A24%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%20II%20study%20of%20combining%20vinblastine%20and%20cyclosporin-A%20to%20circumvent%20multidrug%20resistance%20in%20renal%20cell%20cancer&rft.jtitle=Annals%20of%20oncology&rft.au=Rodenburg,%20C%20J&rft.date=1991-04&rft.volume=2&rft.issue=4&rft.spage=305&rft.epage=306&rft.pages=305-306&rft.issn=0923-7534&rft_id=info:doi/10.1093/oxfordjournals.annonc.a057941&rft_dat=%3Cproquest_cross%3E80730878%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2221-42a1bf45ee91b978dd03755d8615881705edf80a010c0907cb22d1c5e626ce13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80730878&rft_id=info:pmid/1868026&rfr_iscdi=true